Baxter International Inc. · NYSE:BAX

Baxter International — Presentation (July 2023)

13 slides from Baxter International's investor presentation, Jul 6, 2023

  1. Slide 1: Stockholder Engagement

    STOCKHOLDER ENGAGEMENT 1 Baxter International Inc. July 2023 Exhibit 99.1

  2. Slide 2: Safe Harbor Statement

    SAF E H AR B O R S TAT E M E N T 2Baxter International This presentation includes forward-looking statements concerning the company’s financial results, business development and regulatory activities (including anticipated benefits and estimated timing) and Baxter’s 2030 Corporate Responsibility Com

  3. Slide 3: Baxter Profile

    B AXT E R P RO F I L E 1 3Baxter International $15.1B FY 2022 Global Revenue2 Renal Care $3,748M Medication Delivery $2,886M Pharmaceuticals $2,126M Clinical Nutrition $931M Advanced Surgery $998M Acute Therapies $701M BioPharma Solutions $644M Patient Support Systems $1,487M Front Line Care $1,148M

  4. Slide 4: Proposed Spin Should Position Both Businesses to Drive Enhanced Value Through Innovation

    P RO P O S E D S P I N S H O U LD P O S I T I O N B OT H B U S I N E S S E S TO D R I V E E N H AN C E D VALU E T H RO U G H I N N OVAT I O N 4Baxter International > Greater focus, flexibility in R&D investment > Address global shift to home, alternate sites of care > Accelerate emphasis on device c

  5. Slide 5: Business Overview

    5 Business Overview > Leading global medical technology company fundamentally focused on medically essential products and transformative innovation to advance our Mission to Save and Sustain Lives > Accelerating our enterprise-wide transformation and positioning for growth with the proposed spinoff

  6. Slide 6: Strategic Actions to Help Enhance Operational Effectiveness and Drive Further Long-Term Stockholder Value

    S T R AT E G I C AC T I O N S TO H E L P E N H AN C E O P E R AT I O N AL E F F E C T I V EN ES S AN D D R I V E F U R T H E R LO N G -T E R M S TO C K H O L D E R VALU E 6Baxter International Positioning both businesses for accelerated growth as global medical technology leaders 1Name of spinoff co

  7. Slide 7: Industry Leading Performance: Operational Excellence

    I N D U S T RY L E AD I N G P E R FO R M AN C E : O P E R AT I O N AL E XC E L LE N CE 7Baxter International Optimizing Manufacturing, Supply Chain to Enhance Network Efficiencies Manufacturing footprint network optimization > Sites being streamlined, mapped directly to each new global business segm

  8. Slide 8: Highly Experienced and Qualified Board Overseeing Execution and Business Transformation

    H I G H LY E XP E R I EN CED AN D Q UAL I F I E D B OAR D OV E R S E E I N G E XE C U T IO N AN D B U S I N E S S T R AN S FO R M AT I O N 8Baxter International José (Joe) E. Almeida Chairman, President and Chief Executive Officer Former Chairman, President & CEO, Covidien William (Bill) Ampofo VP,

  9. Slide 9: Extensive Stockholder Engagement Program

    E XT E N S I V E S TO C K H O LD E R E N G AG E M E N T P RO G R AM 9Baxter International Robust Engagement Year-Round 2022 Outreach Statistics1 Our Board, along with our Investor Relations team and other select members of the management team, is committed to engaging in constructive dialogue with s

  10. Slide 10: Executive Compensation Aligned with Strategic Priorities

    E XE C U T IV E C O M P E N SAT I O N AL I G N E D W I T H S T R AT E G I C P R I O R I T IES 10Baxter International CEO Pay Mix (2022) 9% 15% 19% 19% 38% 91% Variable/ “At-Risk” Pay Element Objectives Base Salary  Provides a base level of competitive compensation  Used to attract and retain execu

  11. Slide 11: Commitment to Strengthening Pay-for-Performance Alignment and Executive Compensation Program

    C O M M I T M E N T TO S T R E N GT HEN I N G PAY- FO R -PE RFO RM AN CE AL I G N M E N T AN D E XE C U T IV E C O M P E N SAT I O N P RO G R AM 11Baxter International 2020--2022 Pay-for-Performance Alignment 2023 Executive Compensation Program Changes ► For the 2023 annual incentive plan, the follo

  12. Slide 12: Corporate Responsibility Goals

    2 0 3 0 C O R P O R AT E R E S P O N S I B I L I T Y G OALS 12 PILLARS GOALS PERFORMANCE Reach More Underserved Kidney Patients Double the number of patients reached in underserved markets* through our peritoneal dialysis (PD) portfolio. *Countries outside of the United States, Canada, Western Europ

  13. Slide 13: Select 2022 Awards and Recognitions

    13 Select 2022 Awards and Recognitions: Disability:IN Best Place to Work for Disability Inclusion CDP Management in Climate and Water EcoVadis Gold Sustainability Rating S&P Global Dow Jones Sustainability Indices Wall Street Journal Management Top 250 Human Rights Campaign Foundation Corporate Equa

Baxter International — Presentation (July 2023) on 6ix